You are here

Algernon Pharmaceuticals Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
AGN
CSE Index: 
Currency: 

Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.

You are here

Algernon Pharmaceuticals Inc. (AGN)

SEDAR Information

Company Info

Address
Suite 1500 - 1055 West Georgia Street
Vancouver, BC V6E4N7
Canada
Phone
604-398-4175
Ext
701
Email
info@algernonpharmaceuticals.com
Website
http://algernonpharmaceuticals.com
Listing date
Monday, February 1, 2016
Transfer Agent
TSX Trust Company
Auditor
Smythe LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
9,653,724
Reserved for Issuance: 
4,968,996

Bulletins

01/03/2023

2023-0303 – Stock Split - Algernon Pharmaceuticals Inc. (AGN)

le 1 mars/March 2023

Algernon Pharmaceuticals Inc. has announced a four (4) for one (1) stock split of its issued and outstanding common shares. Each shareholder of record as of the close of business on the record date will receive three (3) additional shares for each share held on such date.

Advertisement

Publicité

Latest CSE News